KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inovio Pharmaceuticals (INO) Tax Provisions (2018 - 2019)

Historic Tax Provisions for Inovio Pharmaceuticals (INO) over the last 3 years, with Q4 2019 value amounting to -$87764.0.

  • Inovio Pharmaceuticals' Tax Provisions changed N/A to -$87764.0 in Q4 2019 from the same period last year, while for Sep 2020 it was -$87764.0, marking a year-over-year increase of 4824.35%. This contributed to the annual value of -$257335.0 for FY2019, which is 11185.88% down from last year.
  • As of Q4 2019, Inovio Pharmaceuticals' Tax Provisions stood at -$87764.0.
  • In the past 5 years, Inovio Pharmaceuticals' Tax Provisions registered a high of $2.2 million during Q1 2018, and its lowest value of -$1.8 million during Q3 2015.
  • Over the past 3 years, Inovio Pharmaceuticals' median Tax Provisions value was -$97267.5 (recorded in 2019), while the average stood at -$30881.7.
  • Examining YoY changes over the last 5 years, Inovio Pharmaceuticals' Tax Provisions showed a top increase of 10289.43% in 2019 and a maximum decrease of 10289.43% in 2019.
  • Quarter analysis of 3 years shows Inovio Pharmaceuticals' Tax Provisions stood at -$308520.0 in 2015, then skyrocketed by 803.3% to $2.2 million in 2018, then tumbled by 104.04% to -$87764.0 in 2019.
  • Its Tax Provisions stands at -$87764.0 for Q4 2019, versus -$106771.0 for Q2 2019 and -$62800.0 for Q1 2019.